Nuvation Bio Inc - Ordinary Shares - Class A

NYSE:NUVB   4:00:00 PM EDT
-0.12 (-3.53%)
6:40:03 PM EDT: $3.35 +0.07 (+2.13%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Nuvation Bio Inc - Ordinary Shares - Class A Stock, NYSE:NUVB

1500 Broadway, Suite 1401, New York, New York 10036
United States of America
Phone: +1.332.208.6102
Number of Employees: 51


Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.